International Cannabis Weekly: 327

LEAKED DOCUMENTS SUGGEST SIGNIFICANT CHANGES – AND FURTHER DELAYS – TO GERMANY’S CANNABIS ACT

Germany’s traffic light coalition has reportedly agreed on significant changes to the country’s landmark cannabis act, which could now be enacted in two separate parts.

READ MORE  »

REGULATORS APPROVE LAWSUIT SETTLEMENTS IN NEW YORK LICENSING IMPASSE

READ MORE »

JAZZ PHARMA’S EPIDIOLEX RECEIVES AUTHORISATION FROM HEALTH CANADA

READ MORE »

• Luxembourg’s new coalition government puts adult-use cannabis legalisation on standby.
• Rokshaw unveils Four20 medical cannabis products, now available for private prescription in the UK.
• SOMAÍ Pharmaceuticals to produce EU-GMP-certified extracted cannabis APIs and products for Canna Forest.
• BZAM Ltd. and 4C Labs finalise key distribution partnership, seeing the first shipment of medical flower to the UK.
• Releaf reveals effects of persistent stigma five years since medical cannabis was legalised in the UK.
• Danish medical cannabis company Stenocare enters the Australian medical cannabis market.

READ WEEKLY STOCK REPORT »

• Two-thirds of voters in Florida are in favour of cannabis legalisation, according to a new poll.
• New Hampshire Governor calls for a 15-store cap on cannabis dispensaries in the state.
• Rapper and Cookies co-founder, Berner, joins Last Prisoner Project to free Air Force veteran.
• MailOrder420 platform is now operational, enabling lawful mail-order distribution of cannabis across the US.
• US Department of Agriculture (USDA) revokes hemp farmers’ licences nationwide amidst legal ambiguities.
• Body and Mind concludes California transaction, retiring 1.65 Million shares to treasury in strategic move.

SHOP NOW »

• Canadian cannabis market ‘struggling for survival’ just five years after adult-use legalisation.
• Statistics Canada reports dip in September cannabis sales, sliding 4.9% to C$444.0 million.
• Cannabis MSO Joshi Holdings files a shelf prospectus in Canada to raise up to C$600 million.
• Cronos Group, owner of Peace Naturals, sells Clearview Township fability, leasing back a portion to continue operations.
• High Tide set to expand its retail presence with of launch new Canna Cabana store in Winnipeg, Manitoba.
• Canadabis Capital, alongside Sub Stigma Grow, reports record fiscal year 2023 with notable gains in revenue and profit.

LAST CHANCE – SHOP NOW »

• The National Agricultural Labor Commission in Argentina establishes regulations for medicinal cannabis.
• Chamber public hearing tackles cannabis cultivation regulations in Brazil and discusses enhanced production.
• São Paulo City Council hosts first conference on medicinal cannabis to elevate regulatory discussions.
• PharmaCielo reveals Q3 2023 financial results, reporting net loss of C$2.76 million, down from C$5.18 million in 2022.

• Swinburne University researchers discover medicinal cannabis has limited impact on cognitive function.
• Bod Science voluntarily suspended from ASX amid transaction vital to the company’s future prospects.
• A top Tokyo university is disbanding its 83-year-old American football team after players’ cannabis possession charges.
• French Polynesia assembly votes to repeal 2023 cannabis laws, hindering the path to medical cannabis legalisation.

• Significant drop in medical cannabis import-export in Israel, with 16 tons imported and just half-a-tonne exported.
• South African cannabis industry faces ‘policy uncertainty, market saturation and poor agricultural processes’.